Drug Search Results
More Filters [+]

Pentamidine

Alternative Names: pentamidine, pentacarinat, nebupent, pentam, pentam 300
Latest Update: 2024-08-13
Latest Update Note: Clinical Trial Update

Product Description

Pentamidine is used to try to prevent Pneumocystis carinii pneumonia (PCP), a very serious type of pneumonia. This type of pneumonia occurs commonly in patients whose immune systems are not working normally, such as patients with acquired immune deficiency syndrome (AIDS). (Sourced from: https://www.mayoclinic.org/drugs-supplements/pentamidine-inhalation-route/side-effects/drg-20065369?p=1)

Mechanisms of Action: DNA Synthesis Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intramuscular,Intravenous,Topical

FDA Designation: None *

Approval Status: Approved

Approved Countries: Australia | Belgium | Brazil | Canada | Chile | Colombia | Czech | France | Germany | Greece | Hong Kong | Ireland | Italy | Korea | Luxembourg | Malaysia | Malta | Netherlands | New Zealand | Peru | Portugal | Singapore | Slovenia | South Africa | Spain | Sweden | Switzerland | Taiwan | Thailand | United Kingdom | United States

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Pentamidine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events